4th Annual Optimizing Clinical Trials
The challenging economic times have lead to a critical review of all clinical development programs, and change the nature of clinical trials considerably. Companies are being forced to critically re-assess their core competencies, and an increasing amount of emphasis is being put on research cost-effectiveness, outsourcing services from developing countries, and creativity in study design.
Clinical research is a multi-billion dollar business and the major challenge for pharmaceutical companies in the next 5 years is to maintain high growth rates, and understand how this market will change in the future, and what impact this will have on future business opportunities.
Participants will have the opportunity to share their experience and knowledge, and explore the range of hurdles and issues that contribute to many of the challenges being faced in clinical drug development today. Participants will learn and network with top industry leaders and peers and from all areas of clinical trials.
This programme will feature presentations and case studies from industry experts, and will provide an interactive learning opportunity. Your attendance is a must if you wish to remain up to date with the most complex of markets.
· The effect of partnerships on clinical trials · RECRUITMENT: Boosting patient participation · TECHNOLOGY: Inefficient data collection · Challenge of Lab Sampling and Pharmacokinetics in Neonatology · Implementing multinational trials on local level · Collaboration between CRO and Clinical Data Management: How to make it work · Budgets for Clinical Research in time of financial crisis · Use of academic laboratories in clinical development to foster collaborative research · Reinventing Clinical Quality Assurance: from compliance to quality risk management and how this has also transformed our approach to study management · Partnership in Clinical Trials, a tender relationship – an Industry view on getting it right
Some of the Distinguished Speakers include:
Astellas Pharma Europe B.V. - Associate Director Clinical Pharmacology Research Management
AstraZeneca - Clinical information Science Director,
AstraZeneca - Clinical Research Director (Russia and Ukraine), Clinical Research Region CEEMEA
Baxter AG - Senior Director Global Clinical Operations & Global Clinical and Medical Affairs
Bayer Schering Pharma - Global Head Data Management
GlaxoSmithKline Oncology - Principal Clinical Development Scientist
H. Lundbeck A/S - Head of Clinical Supply Packaging
Merck Serono - Global Clinical Monitoring Lead
Novartis - Senior Medical Director
Novo Nordisk - Acting Head of Clinical Research
Orphan Europe - Medical Director, Head of Medical Affairs
Roche Global Development - Global Head Clinical Development
Roche Pharmaceuticals - Head of Programming
Sanofi Aventis - Clinical Investigational Product Project Manager Leader
Shire Pharmaceuticals - Director, International Clinical Development and Medical Affairs
Who should attend?
Members of the Board, Vice Presidents, Directors, Head and Senior Managers involved in the areas of:
